Methods and Compositions for Promoting Survival and Proliferation of Endothelial Cells and Stimulating Angiogenesis
Cornell Research Foundation, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 12/523,372, filed Dec 22, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,944,897 | Methods and Compositions for Promoting Survival and Proliferation of Endothelial Cells and Stimulating Angiogenesis In force · High confidence | Cornell Research Foundation, Inc. | In force | High confidence | ||
| US 10,865,379 | Methods and Compositions for Promoting Survival and Proliferation of Endothelial Cells and Stimulating Angiogensis In force · High confidence | Cornell Research Foundation, Inc. | In force | High confidence | ||
| US 12,753,384 | Methods and Compositions for Promoting Survival & Proliferation of Endothelial Cells & Stimulating Angiogenesis In force · Low confidence | Cornell Research Foundation, Inc. | In force | Low confidence | ||
| US 8,465,732 | Endothelial Cells Expressing Adenovirus E4ORF1 and Methods of Use Thereof In force · High confidence | Sloan-Kettering Institute for Cancer Research | In force | High confidence | ||
| US 11,913,021 | Methods and Compositions for Promoting Survival and Proliferation of Endothelial Cells and Stimulating Angiogensis In force · High confidence | Cornell Research Foundation, Inc. | In force | High confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Cornell Research Foundation, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.